Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

AstraZeneca leukaemia treatment recommended for NHS use

March 18, 2021
AstraZeneca, NHS

AstraZeneca has announced today that its oral targeted cancer therapy, Calquence (acalabrutinib), has been recommended by NICE for routine use …

News
az

AstraZeneca vaccine suspended in 11 European countries

March 16, 2021
Manufacturing and Production AstraZeneca

Blood clot fears have caused 11 European countries to suspend the use of the Oxford-AstraZeneca vaccine. France, Germany, Italy, and …

News
astrazeneca_sign_sky

Netherlands suspends AstraZeneca vaccine despite safety assurances

March 15, 2021
Medical Communications, Sales and Marketing AstraZeneca, COVID-19, EMA, EU, WHO

The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca vaccine amid concerns it may cause …

News
astrazeneca_plaque

AstraZeneca wins US court ruling on Symbicort patent claims

March 3, 2021
Research and Development AstraZeneca, Symbicort, law

A US district court has ruled in favour of AstraZeneca in litigation against Mylan Pharmaceuticals and Kindeva Drug Delivery, AstraZeneca …

News

Single Pfizer or AstraZeneca vaccine dose drastically reduces COVID-19 hospitalisations in over-80s

March 2, 2021
Manufacturing and Production AstraZeneca, COVID-19, COVID-19 vaccine, Pfizer, Vaccine

A single dose of the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine reduces UK hospitalisations in over-80s by 80%, a Public Health …

News
astrazeneca_plaque

AstraZeneca to withdraw Imfinzi US indication for bladder cancer

February 22, 2021
Sales and Marketing AstraZeneca, Imfinzi

AstraZeneca will voluntarily withdraw the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or …

News
lynparza

AstraZeneca and MSD’s Lynparza crosses superiority boundary for invasive disease-free survival

February 17, 2021
Research and Development AstraZeneca, Cancer, MSD

The OlympiA Phase III trial for AstraZeneca and MSD’s cancer drug Lynparza will move to early primary analysis and reporting, …

News
who_flag

WHO approves two versions of AstraZeneca’s COVID-19 vaccine

February 16, 2021
Manufacturing and Production AstraZeneca, COVID-19, WHO

The WHO has greenlighted two versions of the Oxford-AstraZeneca COVID-19 vaccine for emergency use, granting them authorisation to be rolled …

News
enhertu

Daiichi Sankyo and AstraZeneca’s breast cancer drug Enhertu approved in UK

February 16, 2021
Manufacturing and Production AstraZeneca, Cancer, Daiichi Sankyo

Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has been granted conditional authorisation in the UK as a monotherapy for the …

News
astrazeneca_sign_sky

AstraZeneca’s COVID-19 vaccine to be trialled in children

February 15, 2021
Sales and Marketing AstraZeneca, COVID-19

The Oxford-AstraZeneca COVID-19 vaccine is to be tested on children in the UK in a new trial commencing this month. …

News
who_flag

AstraZeneca COVID-19 vaccine still restricted, despite WHO assurances

February 12, 2021
Medical Communications AstraZeneca, COVID-19

Several European countries have continued to impose age restrictions on their rollouts of the Oxford University-AstraZeneca vaccine, despite WHO’s repeated …

News
who_flag

WHO panel recommends AstraZeneca COVID-19 vaccine for over-65s

February 11, 2021
AstraZeneca, COVID-19, WHO

Scientists advising the WHO have recommended the use of the Oxford-AstraZeneca COVID-19 vaccine in all adults, including those aged over …

News
astrazeneca_sign_sky

South Korea approves AstraZeneca COVID-19 vaccine for use

February 10, 2021
Research and Development AstraZeneca, COVID-19

South Korea is to grant first approval for the Oxford University-AstraZeneca vaccine later today, with the rollout expected to start …

News
astrazeneca_building_white

South Africa halts rollout of AstraZeneca’s COVID-19 vaccine amid efficacy concerns

February 8, 2021
Sales and Marketing AstraZeneca, COVID-19

AstraZeneca is racing to adapt its COVID-19 vaccine as new data suggests it offers little protection against the more dominant …

News
astrazeneca-sign

New Oxford University-AstraZeneca vaccine against COVID-19 mutations could be available by October

February 5, 2021
Medical Communications AstraZeneca, COVID-19

Oxford University and AstraZeneca could release a new vaccine by October in order to counter the new mutations of COVID-19 …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025